Provided is a hybridoma deposited under the accession No. FERM BP-10376 capable of producing an antibody against TARM protein. Further provided as uses of TARM and TARM-L antibodies to manufacture medicaments inhibiting interaction between TARM and TARM-L and methods of assaying for the said interaction.